Newsletter

003090 - Daewoong Co., Ltd.

003090 Summary
Biopharma
Stock Price & Overview
₩16,860 -340 (-1.98%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩16,860  ≈ US$12  ·  Market cap ₩1.0tn (≈ $700m)
Home › 003090 › Filings

New Facility Investment

DART
Daewoong Co., Ltd.
Filed Jun 30, 2026 KST · Capex · receipt 20260630801612

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 신규시설투자등(자회사의 주요경영사항)

003090

Price
₩16,860
Change
-1.98%
Market cap
₩1.0tn
Prev. close
₩17,200
003090 SummaryCompare to Peers

More 003090 filings

Debt guarantee for a third party (subsidiary)

09/04/26

Litigation Filed

09/02/26

Half-Year Report

08/14/26

Material matter affecting investment judgment (subsidiary)

07/10/26

Single Supply Contract Signed

06/26/26

Material matter affecting investment judgment (subsidiary)

06/23/26